Market Movers

Xeriant Press Conference

Xeriant, Inc. (OTCQB: XERI)  https://www.youtube.com/watch?v=p4q4m0uk8i4 Xeriant Press Conference >> https://www.xeriant.com/august-2022-press-conference About Xeriant, Inc. Xeriant, Inc. (d.b.a. Xeriant Aerospace) is an...

24/7 MN (NASDAQ: CDTX) CIDEARA THEREPEUTICS INC shares are moving up more than 14% in pre-market as they announce the submission of a NDA or new drug application to the FDA.

More than 700,000 in volume and 888 trades as of this post. The stock is bid at .79 https://www.globenewswire.com/news-release/2022/07/27/2486833/35407/en/Cidara-Therapeutics-Submits-NDA-for-Rezafungin-and-Announces-License-Agreement-with-Melinta-Therapeutics-for-Commercialization-of-Rezafungin-in-the-U-S.html